1. Home
  2. AEMD vs BBLG Comparison

AEMD vs BBLG Comparison

Compare AEMD & BBLG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Aethlon Medical Inc.

AEMD

Aethlon Medical Inc.

HOLD

Current Price

$0.68

Market Cap

2.1M

Sector

Health Care

ML Signal

HOLD

BBLG

Bone Biologics Corp

HOLD

Current Price

$1.25

Market Cap

2.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AEMD
BBLG
Founded
1984
2004
Country
United States
United States
Employees
N/A
2
Industry
Medical/Dental Instruments
Industrial Specialties
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.1M
2.5M
IPO Year
2008
N/A

Fundamental Metrics

Financial Performance
Metric
AEMD
BBLG
Price
$0.68
$1.25
Analyst Decision
Hold
Analyst Count
1
0
Target Price
$15.00
N/A
AVG Volume (30 Days)
196.1K
47.6K
Earning Date
02-12-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.51
$1.05
52 Week High
$5.89
$4.13

Technical Indicators

Market Signals
Indicator
AEMD
BBLG
Relative Strength Index (RSI) 24.92 39.37
Support Level $0.64 $1.08
Resistance Level $0.83 $1.38
Average True Range (ATR) 0.12 0.09
MACD 0.01 -0.02
Stochastic Oscillator 6.47 9.09

Price Performance

Historical Comparison
AEMD
BBLG

About AEMD Aethlon Medical Inc.

Aethlon Medical Inc is a medical therapeutic company focused on developing the Hemopurifier (HP), a clinical-stage investigational immunotherapeutic device designed to address unmet needs in oncology, life-threatening infectious diseases, organ transplantation and other disease states in which extracellular vesicles (EVs) contribute to disease progression. The Hemopurifier utilizes a proprietary lectin-based technology to bind and remove enveloped viruses and EVs from biological fluids. EVs have been associated with immune suppression, metastasis, and resistance to therapy in cancer, as well as progression of severe infectious diseases. The Company operates as a single reportable segment.

About BBLG Bone Biologics Corp

Bone Biologics Corp a medical device company that is currently focused on bone regeneration in spinal fusion using the recombinant human protein known as NELL-1. NELL-1 in combination with DBM, demineralized bone matrix, is an osteopromotive recombinant protein that provides target specific control over bone regeneration. It is a clinical-stage entity. The production and marketing of its products and ongoing research and development activities are subject to extensive regulation by numerous governmental authorities in the United States.

Share on Social Networks: